Injective INJ
Current Price
$3.64 -0.71%
$0.3000 Daily Range (8.24%)
$3.47$3.77
$59.47M Daily Volume
781 BTC
Vol/MktCap: 16.32%
Market Performance
0.08% Relative BTC Volume
The total volume of Injective is $59.47M over the past 24 hours, compared to $75.22B total Bitcoin volume.
Hourly Moving Average
8 SMA $3.63 +0.20%
13 SMA $3.64 -0.02%
21 SMA $3.65 -0.25%
55 SMA $3.62 +0.44%
144 SMA $3.82 -4.66%
Price Performance
+0.92% 1 Hour Change
$3.64 from $3.61
-17.83% 7 Day Change
-$0.6489 from $4.29
-21.19% 14 Day Change
-$0.7712 from $4.41
-29.22% 30 Day Change
-$1.06 from $4.70
All Time High
March 14, 2024
$52.62 -93.07%
-$48.97 vs. now
24H Change
-2.60M USD -0.71%
-34 BTC
Volume and Supply
Total Supply: 100.00M INJ 
100.00M INJ Available100.00% circulating A lower circulating supply may increase over time, reducing scarcity and potentially causing a drop in price. A higher circulating supply is less susceptible to dilution, offering the potential for a more stable price long-term.
Relative Supply Ratio
5.00 x BTC Supply5:1 supply ratio
RSR reflects potential differences in tokenomics, such as inflation rates, utility, or burn mechanisms, which can impact long-term value and scarcity.
Relative Trade Volume
16.43M INJ
traded over past 24 hours
16.43% of circulating supply
A higher trade volume relative to market cap indicates strong market activity and liquidity, while a lower ratio may suggest reduced interest, lower liquidity, or potential price stagnation.
Conversion Tool
Injective AI Market Analysis
Injective (INJ) is currently trading at $3.62, showing a slight decline of 0.10% over the past 24 hours. The daily price action has remained within a range of $3.47 to $3.77, indicating a relatively tight trading range with a daily volatility of only 0.3%.
Trading volume has been significant at 59,040,338, which corresponds to a volume-to-market cap ratio of 16.27%, suggesting healthy market activity. However, the hourly moving averages present a bearish outlook; the 8 SMA is at $3.63 (-0.35%), and the 144 SMA is notably lower at $3.82 (-5.18%), indicating downward pressure over the longer term.
The Relative Strength Index (RSI) readings show a mixed sentiment; the 1-hour RSI is neutral at 49, while the 7-day RSI at 41 indicates a bearish momentum. Over the past 7, 14, and 30 days, the price has significantly decreased by approximately 18.40%, 21.10%, and 31.02%, respectively, reflecting a strong downtrend.
Injective's all-time high of $52.62, achieved earlier this year, indicates substantial potential for recovery if bullish sentiment returns. However, the current price action and momentum indicators suggest that the asset is still in a bearish phase, with significant resistance ahead before approaching prior highs.
Given the technical indicators and current market sentiment, the recommendation for Injective (INJ) is to Hold. This stance allows for a reassessment in the face of potential recovery signals while avoiding further losses if the downtrend continues. A shift to a Buy rating would require a clear break above the $3.80 resistance level with accompanying volume and bullish momentum.
Trading volume has been significant at 59,040,338, which corresponds to a volume-to-market cap ratio of 16.27%, suggesting healthy market activity. However, the hourly moving averages present a bearish outlook; the 8 SMA is at $3.63 (-0.35%), and the 144 SMA is notably lower at $3.82 (-5.18%), indicating downward pressure over the longer term.
The Relative Strength Index (RSI) readings show a mixed sentiment; the 1-hour RSI is neutral at 49, while the 7-day RSI at 41 indicates a bearish momentum. Over the past 7, 14, and 30 days, the price has significantly decreased by approximately 18.40%, 21.10%, and 31.02%, respectively, reflecting a strong downtrend.
Injective's all-time high of $52.62, achieved earlier this year, indicates substantial potential for recovery if bullish sentiment returns. However, the current price action and momentum indicators suggest that the asset is still in a bearish phase, with significant resistance ahead before approaching prior highs.
Given the technical indicators and current market sentiment, the recommendation for Injective (INJ) is to Hold. This stance allows for a reassessment in the face of potential recovery signals while avoiding further losses if the downtrend continues. A shift to a Buy rating would require a clear break above the $3.80 resistance level with accompanying volume and bullish momentum.
Updated 206 minutes ago.
Injective Relative Price at Market Cap of:
Injective TradingView Chart
In The News

C. Thi Nguyen: Prioritizing enjoyment over efficiency in games, the pitfalls of social media scoring systems, and how metrics can obscure true value | Bankless
Rethinking success: How game mechanics shape our values and influence social media…

'Big Short' Michael Burry flags “death spiral” after silver liquidations beat bitcoin
Tokenized silver futures logged one of the largest wipeouts across crypto markets, overtaking the usual leaders bitcoin and ether.

Canada’s investment watchdog rolls out crypto custody rules to avoid another QuadrigaCX
CIRO’s new digital asset custody framework takes effect immediately, raising standards for crypto trading platforms as regulators push to reduce investor risk.

Dogecoin (DOGE) and Shiba Inu (SHIB) Lose $5B Combined in Market Cap, Whales Shift Focus
The first half of February 2026 is proving to be a wake-up call for the meme coin sector.